Skip to main content
OpenTrials
Completed

NCT Number: NCT04340037

Prediction of Sepsis After Percutaneous Nephrolithotomy

We aim to determine the preoperative predictors of sepsis after percutaneous nephrolithotomy (PCNL) in patients with unilateral, solitary and proximal ureteral stones.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Percutaneous Nephrolithotomy Albumin Globulin Ratio Female Urogenital Diseases Female Urogenital Diseases and Pregnancy Complications Infection Infections Male Urogenital Diseases Urogenital Diseases Urolithiasis Urologic Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology

Wuhan, Hubei, 430030, China

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • (1) PCNL was performed to treat unilateral, solitary, and proximal ureteral stones; and (2) age ≥18 years

Exclusion criteria

  • anatomical renal abnormalities (horseshoe kidney, solitary kidney, transplant kidney and kidney duplication)

Treatment and study plan

percutaneous nephrolithotomy

Procedure

percutaneous surgery using nephroscope

Primary outcomes

  1. sepsis

    Time frame: within 48 hour after surgery

    the concurrence of infection and a minimum of two of the following within 48 hours of surgery: (1) heart rate >90/minute, (2) body temperature >38°C, (3) leukocyte count <4,000 cells/μL or >12,000 cells/μL, and (4) respiratory rate >20/minute

Sponsors and collaborators

Lead sponsor

Tongji Hospital

Other

Registry information

Official study title

A Pre-operative Nomogram for Sepsis After Percutaneous Nephrolithotomy Treating Solitary, Unilateral, and Proximal Ureteral Stones

Important dates

Study start
2019
Primary completion
2020
Study completion
2020
First posted
Apr 9, 2020
Registry last updated
Apr 9, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.